IRON
Disc Medicine, Inc. · Healthcare
65.08
1.12%(-0.74)
Market OpenLast Updated: — ET
52W L: $30.8252W H: $99.50
$65.16
CHG+4.81 (+7.97%)
H$67.15
L$57.00
VOL8.5M
IRON (1h)
IRON NEWS
defenseworld.net
10h ago
SG Americas Securities LLC Buys 13,058 Shares of Disc Medicine, Inc. $IRON
SG Americas Securities LLC boosted its stake in shares of Disc Medicine, Inc. (NASDAQ: IRON) by 161.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 21,122 shares of the company's stock after purchasing an additional 13,058 shares during the quarter. SG Americas
defenseworld.net
12h ago
Aberdeen Group plc Purchases 202,297 Shares of Disc Medicine, Inc. $IRON
Aberdeen Group plc grew its stake in shares of Disc Medicine, Inc. (NASDAQ: IRON) by 631.0% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 234,358 shares of the company's stock after buying an additional 202,297 shares during the period.
newsfilecorp.com
1d ago
Investors in Disc Medicine, Inc. (IRON) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - April 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Disc Medicine, Inc. (NASDAQ: IRON) ("Disc Medicine, Inc.") concerning potential violations of the federal securities laws. On February 13, 2026, Disc disclosed that the FDA had issued a Complete Response Letter (CRL) for bitopertin, the company's lead therapeutic candidate targeting EPP, a rare genetic disorder characterized by extreme photosensitivity.
globenewswire.com
3d ago
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.
prnewswire.com
5d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. ("Disc" or the "Company") (NASDAQ: IRON). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
prnewswire.com
6d ago
IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine
Investigation examines gap between reported figures and GAAP results at Disc Medicine ahead of its 21.9% stock collapse NEW YORK, April 1, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating whether Disc Medicine, Inc. (NASDAQ: IRON) and certain of its officers fulfilled their disclosure obligations to investors in the period leading up to the company's announcement of a Complete Response Letter from the FDA. Shareholders who purchased IRON shares and incurred losses may obtain further information by contacting Levi & Korsinsky.